TIAA CREF Investment Management’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$6.79M Sell
2018
Q4
$12.4M Buy
2018
Q3
$5.08M Buy
2018
Q2
$717K Buy
2018
Q1
$241K Buy
2017
Q4
$249K Sell
2017
Q3
$457K Hold
2017
Q2
$586K Buy
2017
Q1
$167K Buy
2016
Q4
$60K Buy